BFLY vs PRE vs VREX Stock Comparison

Butterfly Network, Prenetics Global and Varex Imaging Prices as of Oct 28, 2026 Peers: Industry group
1 more company in this comparison (NEOG) Create a free account to keep reading and compare up to 10 companies.
BFLY Butterfly Network, Inc.
$7.82 -14.5% 1M +253.8% 1Y
Market cap
$1.86B
P/E
–
Revenue (TTM)
$112.15M
Div. yield
–
Diagnostic Equipment Healthcare
3 wins
PRE Prenetics Global Ltd
$18.52 -18.6% 1M +51.4% 1Y
Market cap
$312.51M
P/E
–
Revenue (TTM)
$185.92M
Div. yield
–
Diagnostic Equipment Healthcare
2 wins
VREX Varex Imaging Corp
$18.45 -0.1% 1M +48.1% 1Y
Market cap
$777.63M
P/E
35.1x
Revenue (TTM)
$865.00M
Div. yield
–
Diagnostic Equipment Healthcare
2 wins

Head to Head

7 decided of 12

Butterfly Network leads on 3 of the 12 questions below (Butterfly Network 3, Prenetics Global 2, Varex Imaging 2). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionBFLYPREVREXLeader
Larger companyMarket capitalisation $1.86B $312.51M $777.63M BFLY
Cheaper on earningsLower P/E, profitable companies only -27.4x -3.7x 35.1x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS — — 21.2x –
Faster revenue growthRevenue growth, trailing twelve months +28.1% +513.0% +5.3% PRE
More profitableNet margin, trailing twelve months -66.7% -38.2% 2.6% VREX
Better return on capitalReturn on invested capital — — 6.9% –
Less leveragedLower net debt / EBITDA — — 2.5x –
Higher dividend yieldTrailing dividend yield — 0.00% — –
Better 1-year returnPrice return, last 12 months +253.8% +51.4% +48.1% BFLY
Better 5-year returnAnnualised price return, 5 years -5.4%/yr -30.6%/yr -7.2%/yr BFLY
Less volatileAnnualised volatility, 1 year 115.0% 80.7% 57.4% VREX
Higher overall scoreMean of the five percentile scores vs peers 45/100 51/100 51/100 PRE

Percentile Scorecard

BFLYPREVREX

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisBFLYPREVREX
Valuation 29 #161 of 227 35 #147 of 227 86 #32 of 227
Growth 67 #72 of 219 68 #70 of 219 24 #167 of 219
Profitability 33 #138 of 205 43 #117 of 205 67 #69 of 205
Financial Health 61 #92 of 237 58 #101 of 237 42 #138 of 237
Shareholder Returns 37 #86 of 135 – 34 #89 of 135
Overall 45 51 51
  • BFLY ranked among 247 companies in Medical Devices and Diagnostics
  • PRE ranked among 247 companies in Medical Devices and Diagnostics
  • VREX ranked among 247 companies in Medical Devices and Diagnostics

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodBFLYPREVREXSPY
1 month -14.5%-18.6%-0.1% +0.9%
3 months +10.3%+2.8%+68.5% +5.9%
6 months +58.9%+6.4%+67.3% +8.5%
Year to date +105.8%+17.6%+58.4% +13.3%
1 year +253.8%+51.4%+48.1% +12.4%
3 years +889.9%+230.5%+6.6% +88.1%
3 years, per year +114.8%+49.0%+2.2% +23.5%
5 years -24.2%-83.8%-31.3% +68.2%
5 years, per year -5.4%-30.6%-7.2% +11.0%

Risk

MeasureBFLYPREVREXSPY
Volatility, 1Y 115.0%80.7%57.4% 12.7%
Downside volatility, 1Y 91.7%73.9%49.8% 12.7%
Beta vs S&P 500, 1Y 3.011.531.10 1.00
Return / volatility, 1Y 2.210.640.84 0.98
Max drawdown, 5Y -93.4%-97.6%-78.8% -25.4%
From 52-week high -21.3%-29.4%-0.7% -0.9%
52-week high $9.94$26.25$18.58 $779.14
52-week low $1.97$11.79$9.32 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleBFLYPREVREX
P/E now vs peer median -27.4xmedian 28.8x -3.7xmedian 28.8x 35.1xmedian 28.8x
P/S now vs peer median 16.6xmedian 3.0x 1.7xmedian 3.0x 0.9xmedian 3.0x
EV/EBITDA now vs peer median -24.0xmedian 17.4x -4.2xmedian 17.4x 10.2xmedian 17.4x
P/FCF now vs peer median -66.4xmedian 25.7x -6.1xmedian 25.7x -38.5xmedian 25.7x
P/B now vs peer median 9.8xmedian 2.4x 3.4xmedian 2.4x 1.5xmedian 2.4x
PEG now vs peer median -1.01median 1.03 -0.07median 1.03 -9.17median 1.03

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsBFLYPREVREX
Revenue $112.15M $185.92M $865.00M
Gross profit $59.04M $88.89M $296.90M
Operating income -$79.38M -$61.83M $72.20M
Net income -$74.85M -$71.99M $22.40M
Free cash flow -$28.04M -$51.49M -$20.20M
R&D $38.10M $4.11M $91.40M
EPS (diluted) $-0.29 $-5.06 $0.52
Cash & equivalents $124.66M $59.05M $99.20M
Total debt – – $347.10M
Shares (diluted) 262.10M 14.05M 42.60M
Enterprise value $1.30B $176.24M $323.33M

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricBFLYPREVREX
P/E -27.4x -3.7x 35.1x
P/FCF -66.4x -6.1x -38.5x
P/Operating cash flow -77.5x -6.1x 68.8x
P/S 16.6x 1.7x 0.9x
P/B 9.8x 3.4x 1.5x
P/Tangible book 10.2x 3.4x 1.6x
EV/EBITDA -24.0x -4.2x 10.2x
EV/EBIT -21.9x -4.1x 14.2x
EV/Revenue 15.5x 1.4x 1.2x
EV/FCF -61.9x -4.9x -50.8x
EV/Operating cash flow -72.3x -4.9x 90.8x
PEG (3Y EPS CAGR) -1.01 -0.07 -9.17

Growth

14 metrics
MetricBFLYPREVREX
Revenue growth (1Y) 28.1% 513.0% 5.3%
Revenue CAGR (3Y) 15.6% 115.5% -1.2%
Gross profit growth (1Y) 8.8% 413.6% 6.1%
Gross profit CAGR (3Y) 13.3% 127.9% 1.2%
Operating income growth (1Y) -14.8% -49.2% 297.8%
Operating income CAGR (3Y) 21.1% -1.9% -2.3%
Net income growth (1Y) -19.1% -60.1% 116.7%
Net income CAGR (3Y) 20.8% -16.5% -9.2%
EPS growth (1Y) -12.9% -28.5% 116.1%
EPS CAGR (3Y) 27.0% 52.8% -3.8%
Operating cash flow growth (1Y) 19.6% – -81.1%
Operating cash flow CAGR (3Y) 44.5% – -47.6%
Free cash flow growth (1Y) 12.2% – -155.5%
Free cash flow CAGR (3Y) 42.8% – -33.5%

Profitability

14 metrics
MetricBFLYPREVREX
Gross margin 52.6% 47.8% 34.3%
EBITDA margin -64.4% -32.6% 11.7%
Operating margin -70.8% -33.3% 8.3%
Pretax margin -66.7% -24.2% 3.2%
Net margin -66.7% -38.2% 2.6%
FCF margin -25.0% -27.7% -2.3%
Operating cash flow margin -21.4% -27.7% 1.3%
Return on equity -39.3% -67.3% 4.5%
Return on assets -26.3% -43.8% 2.1%
Return on invested capital – – 6.9%
Return on capital employed -35.1% -48.3% 8.0%
Asset turnover 0.4x 1.1x 0.8x
Cash conversion (OCF / net income) 0.3x 0.7x 0.5x
Stock comp / revenue 21.3% 3.4% 1.7%

Financial Health

11 metrics
MetricBFLYPREVREX
Debt / assets – – 31.6%
Debt / equity – – 0.7x
Net debt / EBITDA – – 2.5x
Debt / FCF – – -17.2x
Liabilities / assets 33.1% 39.5% 53.6%
Equity / assets 66.9% 60.5% 46.4%
Interest coverage -59.4x – 1.9x
Current ratio 4.1x 4.0x 3.4x
Quick ratio 2.7x 1.8x 1.3x
Cash ratio 2.1x 1.6x 0.5x
Altman Z-score 7.69 – 2.29

Shareholder Returns

7 metrics
MetricBFLYPREVREX
Dividend yield – – –
Net buyback yield -0.4% – -0.4%
Shareholder yield -0.4% 0.0% -0.4%
Payout ratio (earnings) – – –
Payout ratio (FCF) – – –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusBFLYPREVREX
Forward P/E – – 21.2xFY2026
EPS, next fiscal year $-0.10FY2026 $-3.42FY2026 $0.87FY2026
EPS growth, next FY – – -3.3%FY2026
EPS growth, the year after – – +14.9%
Revenue, next fiscal year $114.50MFY2026 $234.43MFY2026 $829.68MFY2026
Revenue growth, next FY +17.3%FY2026 +153.7%FY2026 -1.8%FY2026
Revenue growth, the year after +26.0% +65.3% +2.3%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersBFLYPREVREX
Held by institutions 59.9% 0.9% 95.2%
Institutions holding 245 1 186
Change in shares held, QoQ +13.9% – -2.7%
Institutions buying 143 0 98
Institutions selling 59 0 58
Buyers to sellers 2.42 – 1.69

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

BFLYPREVREX
BFLY 1.00 0.25 0.19
PRE 0.25 1.00 0.09
VREX 0.19 0.09 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, BFLY, PRE and VREX?

Butterfly Network (BFLY) is the largest by market capitalisation: Butterfly Network (BFLY) $1.86B, Prenetics Global (PRE) $312.51M, Varex Imaging (VREX) $777.63M.

Which company is growing faster?

Prenetics Global (PRE) grew revenue fastest over the trailing twelve months: Butterfly Network (BFLY) +28.1%, Prenetics Global (PRE) +513.0%, Varex Imaging (VREX) +5.3%.

Which company is more profitable?

Varex Imaging (VREX) has the highest net margin (Butterfly Network (BFLY) -66.7%, Prenetics Global (PRE) -38.2%, Varex Imaging (VREX) 2.6%).

Which stock has performed better?

Over the past year Butterfly Network (BFLY) returned the most: Butterfly Network (BFLY) +253.8%, Prenetics Global (PRE) +51.4%, Varex Imaging (VREX) +48.1%. Over five years, Butterfly Network (BFLY) compounded fastest (Butterfly Network (BFLY) -5.4%/yr, Prenetics Global (PRE) -30.6%/yr, Varex Imaging (VREX) -7.2%/yr). Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, Varex Imaging (VREX) has been the steadiest (Butterfly Network (BFLY) 115.0%, Prenetics Global (PRE) 80.7%, Varex Imaging (VREX) 57.4%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, BFLY, PRE and VREX?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Butterfly Network (BFLY) leads on 3. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.